Life360, Inc.
Life360, Inc. (LIFX) Financial Performance & Income Statement Overview
Explore the financials of Life360, Inc. (LIFX), including yearly and quarterly data on income, cash flow, and balance sheets.
Life360, Inc. (LIFX) Income Statement & Financial Overview
View the income breakdown for Life360, Inc. LIFX across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $103.62M | $115.53M | $92.86M | $84.86M |
| Cost of Revenue | $20.07M | $30.02M | $22.85M | $21.24M |
| Gross Profit | $83.55M | $85.51M | $70.01M | $63.63M |
| Gross Profit Ratio | $0.81 | $0.74 | $0.75 | $0.75 |
| R&D Expenses | $30.40M | $29.79M | $29.01M | $27.01M |
| SG&A Expenses | $50.96M | $50.001M | $45.95M | $38.98M |
| Operating Expenses | $81.36M | $79.79M | $74.96M | $63.63M |
| Total Costs & Expenses | $101.44M | $109.81M | $97.82M | $87.23M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.95M | $2.80M | $2.48M | $2.45M |
| EBITDA | $5.13M | $8.52M | -$2.47M | $85000.00 |
| EBITDA Ratio | $0.05 | $0.07 | -$0.03 | $0.001 |
| Operating Income | $2.19M | $5.72M | -$4.95M | -$2.36M |
| Operating Income Ratio | $0.02 | $0.05 | -$0.05 | -$0.03 |
| Other Income/Expenses (Net) | $1.98M | $564000.00 | $7.91M | -$3.12M |
| Income Before Tax | $4.16M | $6.28M | $2.96M | -$5.49M |
| Income Before Tax Ratio | $0.04 | $0.05 | $0.03 | -$0.06 |
| Income Tax Expense | -$214000.00 | -$2.22M | -$4.73M | $5.48M |
| Net Income | $4.38M | $8.50M | $7.69M | -$10.96M |
| Net Income Ratio | $0.04 | $0.07 | $0.08 | -$0.13 |
| EPS | $57833.94 | $0.04 | $0.03 | -$0.05 |
| Diluted EPS | $52465.48 | $0.03 | $0.03 | -$0.05 |
| Weighted Avg Shares Outstanding | $76.00 | $222.70M | $222.70M | $212.28M |
| Weighted Avg Shares Outstanding (Diluted) | $83.00 | $246.25M | $246.25M | $212.28M |
Over the past four quarters, Life360, Inc. demonstrated steady revenue growth, increasing from $84.86M in Q2 2024 to $103.62M in Q1 2025. Operating income reached $2.19M in Q1 2025, maintaining a consistent 2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $5.13M, reflecting operational efficiency. Net income dropped to $4.38M, with EPS at $57833.94. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan